查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590617

大便潜血试验市场：按产品和最终用户 - 全球预测 2025-2030

Fecal Occult Testing Market by Product (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Immuno-FOB ELISA Test), End-User (Clinical Diagnostic Laboratories, Hospitals, Physicians' Office & Laboratories) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年大便潜血试验市值为1.788亿美元，预计到2024年将达到1.9257亿美元，复合年增长率为7.79%，到2030年将达到3.0237亿美元。

大便潜血试验（FOBT）是一种非侵入性诊断方法，主要用于检测粪便潜血，粪便潜血是大肠直肠癌和其他胃肠道疾病的指标。 FOBT的范围从定期健康检查延伸到早期发现癌症，促进预防保健措施。大肠直肠癌盛行率的不断上升推动了对 FOBT 的需求，从而推动了对易于使用且具有成本效益的筛检解决方案的需求。应用包括家庭检测套组和临床环境中的使用，解决个人健康监测和公共卫生倡议。最终用途范围从医院和诊断实验室到居家医疗机构，支持广泛的潜在就业机会。

主要市场统计
基准年[2023] 1.788 亿美元
预测年份 [2024] 1.9257 亿美元
预测年份 [2030] 30237万美元
复合年增长率（%） 7.79%

影响该市场的主要成长要素包括人们对大肠直肠癌的认识不断提高、政府对癌症筛检的支持政策以及测试敏感性和特异性的进步。此外，老年人口的成长和注重健康的消费者的激增正在推动需求。潜在的机会在于扩大人口覆盖范围、利用数位健康平台进行远端监控以及与医疗保健提供者建立合作伙伴关係以进行宣传活动。利用这些机会的建议包括提高用户便利性、投资研发以提高准确性以及进行策略行销以消除围绕测试的文化偏见。

然而，其局限性包括测试结果的可变性、发展中地区缺乏认识以及来自结肠镜检查和乙状结肠镜检查等替代诊断方法的竞争。监管障碍以及定期测试和检验的需要也阻碍了成长。最佳创新领域包括将人工智慧融入结果分析、开发更敏感的生物标记物以及提高偏远地区人们的检测可及性。 FOBT 市场的动态和竞争性质要求相关人员专注于技术进步和客户教育，以保持市场相关性并推动业务成长。透过策略投资和创新，公司可以克服障碍并提高测试效率和采用率。

市场动态：快速发展的大便潜血试验市场的关键市场洞察

供需的动态交互作用正在改变大便潜血试验市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 直肠癌和结肠癌的盛行率增加
    • 非营利组织和政府的积极努力
    • 越来越注重综合医疗服务，以改善病患体验和健康结果
  • 市场限制因素
    • 大便潜血试验产品相关的高成本
  • 市场机会
    • 对照护现场诊断 (POCD) 的偏好日益增加
    • 大便潜血试验不断取得进展
  • 市场挑战
    • 严格的监管准则和缺乏训练有素的专业人员

波特的五力：驾驭大便潜血试验市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对大便潜血试验市场的影响

外部宏观环境因素对大便潜血试验市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解大便潜血试验市场的竞争状况

大便潜血试验市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵大便潜血试验市场供应商绩效评估

FPNV定位矩阵是评估大便潜血试验市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划大便潜血试验市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，大便潜血试验市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 直肠癌和结肠癌的发生率增加
      • 非营利组织和政府的积极倡议
      • 越来越注重综合医疗服务，以改善病患体验和健康结果
    • 抑制因素
      • 大便潜血试验产品相关的高成本
    • 机会
      • 照护现场诊断 (POCD) 的趋势不断增长
      • 大便潜血试验不断取得进展
    • 任务
      • 严格的监管准则和缺乏训练有素的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章大便潜血试验市场：副产品

  • 癒创木脂 FOB粪便检验
  • 免疫FOB凝集试验
  • 免疫 FOB ELISA 测试
  • 侧流免疫FOB测试

第七章大便潜血试验市场：依最终用户分类

  • 临床诊断实验室
  • 医院
  • 医生办公室和检查室

第八章 北美和南美大便潜血试验市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太大便潜血试验市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲大便潜血试验市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alfa Scientific Designs, Inc.
  • Apacor Limited
  • Beckman Coulter, Inc.
  • Biohit Oyj
  • CTK Biotech, Inc.
  • EDP Biotech Corporation
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • Immunostics, Inc.
  • LifeSign LLC
  • Polymedco, Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Stat Technologies
Product Code: MRR-4348D129FB2A

The Fecal Occult Testing Market was valued at USD 178.80 million in 2023, expected to reach USD 192.57 million in 2024, and is projected to grow at a CAGR of 7.79%, to USD 302.37 million by 2030.

Fecal occult blood testing (FOBT) is a non-invasive diagnostic procedure primarily used to detect hidden blood in stool, which can be an indicator of colorectal cancer or other gastrointestinal disorders. The scope of FOBT extends from regular health check-ups to early cancer detection, promoting preventive healthcare measures. Its necessity stems from the increasing prevalence of colorectal cancer, propelling the demand for accessible and cost-effective screening solutions. Applications include home testing kits and use in clinical settings, catering to both individual health monitoring and public health initiatives. The end-use spectrum ranges from hospitals and diagnostic laboratories to home healthcare agencies, underpinning a versatile adoption potential.

KEY MARKET STATISTICS
Base Year [2023] USD 178.80 million
Estimated Year [2024] USD 192.57 million
Forecast Year [2030] USD 302.37 million
CAGR (%) 7.79%

Key growth factors influencing this market include the rising awareness about colorectal cancer, supportive government policies for cancer screening, and advancements in test sensitivity and specificity. Additionally, the increasing geriatric population, coupled with a surge in health-conscious consumers, fuels demand. Potential opportunities lie in expanding the demographic reach, leveraging digital health platforms for remote monitoring, and fostering collaborations with healthcare providers for awareness campaigns. Recommendations to capitalize on these opportunities include enhancing user convenience, investing in R&D for improved accuracy, and strategic marketing to break cultural stigmas around testing.

However, limitations such as variations in test results, lack of awareness in developing regions, and competition from alternative diagnostic methods like colonoscopy and sigmoidoscopy pose challenges. Regulatory hurdles and the need for periodic test validation can also impede growth. The best areas for innovation involve integrating AI in result analysis, developing more sensitive biomarkers, and improving test accessibility for remote populations. The nature of the FOBT market is dynamic and competitive, requiring stakeholders to focus on technological advancements and customer education to maintain market relevance and drive business growth. With strategic investments and innovation, companies can overcome obstacles and enhance the test's efficacy and adoption.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fecal Occult Testing Market

The Fecal Occult Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of rectal & colon cancer
    • Favorable initiatives by non-profit organizations and governments
    • Rising focus on integrated health services for improved patient experience and health outcomes
  • Market Restraints
    • High cost associated with fecal occult blood test products
  • Market Opportunities
    • Increasing inclination towards point-of-care diagnostics (POCD)
    • Ongoing advances in fecal occult blood tests
  • Market Challenges
    • Stringent regulatory guidelines and dearth of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Fecal Occult Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fecal Occult Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fecal Occult Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fecal Occult Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fecal Occult Testing Market

A detailed market share analysis in the Fecal Occult Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fecal Occult Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fecal Occult Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fecal Occult Testing Market

A strategic analysis of the Fecal Occult Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fecal Occult Testing Market, highlighting leading vendors and their innovative profiles. These include Alfa Scientific Designs, Inc., Apacor Limited, Beckman Coulter, Inc., Biohit Oyj, CTK Biotech, Inc., EDP Biotech Corporation, Eiken Chemical Co., Ltd., Epigenomics AG, Immunostics, Inc., LifeSign LLC, Polymedco, Inc., Quest Diagnostics Incorporated, Quidel Corporation, Randox Laboratories Ltd., and Stat Technologies.

Market Segmentation & Coverage

This research report categorizes the Fecal Occult Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Immuno-FOB ELISA Test, and Lateral Flow Immuno-FOB Test.
  • Based on End-User, market is studied across Clinical Diagnostic Laboratories, Hospitals, and Physicians' Office & Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of rectal & colon cancer
      • 5.1.1.2. Favorable initiatives by non-profit organizations and governments
      • 5.1.1.3. Rising focus on integrated health services for improved patient experience and health outcomes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with fecal occult blood test products
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing inclination towards point-of-care diagnostics (POCD)
      • 5.1.3.2. Ongoing advances in fecal occult blood tests
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory guidelines and dearth of trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fecal Occult Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Guaiac FOB Stool Test
  • 6.3. Immuno-FOB Agglutination Test
  • 6.4. Immuno-FOB ELISA Test
  • 6.5. Lateral Flow Immuno-FOB Test

7. Fecal Occult Testing Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinical Diagnostic Laboratories
  • 7.3. Hospitals
  • 7.4. Physicians' Office & Laboratories

8. Americas Fecal Occult Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Fecal Occult Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Fecal Occult Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alfa Scientific Designs, Inc.
  • 2. Apacor Limited
  • 3. Beckman Coulter, Inc.
  • 4. Biohit Oyj
  • 5. CTK Biotech, Inc.
  • 6. EDP Biotech Corporation
  • 7. Eiken Chemical Co., Ltd.
  • 8. Epigenomics AG
  • 9. Immunostics, Inc.
  • 10. LifeSign LLC
  • 11. Polymedco, Inc.
  • 12. Quest Diagnostics Incorporated
  • 13. Quidel Corporation
  • 14. Randox Laboratories Ltd.
  • 15. Stat Technologies

LIST OF FIGURES

  • FIGURE 1. FECAL OCCULT TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. FECAL OCCULT TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FECAL OCCULT TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. FECAL OCCULT TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. FECAL OCCULT TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FECAL OCCULT TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FECAL OCCULT TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FECAL OCCULT TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY GUAIAC FOB STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY IMMUNO-FOB AGGLUTINATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY IMMUNO-FOB ELISA TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY LATERAL FLOW IMMUNO-FOB TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY PHYSICIANS' OFFICE & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. FECAL OCCULT TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. FECAL OCCULT TESTING MARKET, FPNV POSITIONING MATRIX, 2023